RNS Number : 2185Q
Alumasc Group PLC
17 October 2019
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them
|
1.
|
Details of the person discharging managerial responsibilities / person closely associated
|
|
a.
|
Name
|
Paul Hooper
Andrew Magson
|
|
2.
|
Reason for the notification
|
|
a.
|
Position/status
|
Persons Discharging Managerial responsibility
|
|
b.
|
Initial notification
/Amendment
|
Initial notification
|
|
3.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
a.
|
Name
|
The Alumasc Group plc
|
|
b.
|
LEI
|
2138002MV11VKZFJ4359
|
|
4.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|
a.
|
Description of the
Financial instrument, type
of instrument
Identification code
|
Ordinary 12.5p shares
GB0000280353
|
|
b.
|
Nature of the transaction
|
Grant of shares award under The Alumasc Group plc Long Term Incentive Plan (nil cost option, vesting subject to the satisfaction of performance criteria)
|
|
c.
|
Price(s) and volume(s)
|
Grant
|
PDMR
|
Price(s)
|
Volume(s)
|
|
Paul Hooper
|
Nil cost option
|
149,081
|
|
Andrew Magson
|
Nil cost option
|
69,997
|
|
|
d.
|
Aggregated information
· Aggregated volume
· Price
|
219,078 Ordinary 12.5p shares
0.0 pence per share.
|
|
e.
|
Date of the transaction
|
2019-10-17
10:00 (UTC)
|
|
f.
|
Place of the transaction
|
Outside a trading venue
|
For further information in respect of this announcement please contact:
Helen Ashton, Group Company Secretary +44 (0) 1536 383812
Date of notification: 17 October 2019
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
DSHFFSSUWFUSEFS